Industry NewsLonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range
Industry NewsCN Bio’s PhysioMimix adopted by King’s College London to investigate chronic liver disease
Expert InsightsBiopharmaceuticals webinar series: Explore the latest trends in biopharmaceutical research and development
Industry NewsCN Bio FDA collaboration expanded to investigate lung-on-a-chip model for inhaled drug evaluation applications
Editorial ArticleMeet the winners of the 2021 Scientists’ Choice Awards for Drug Discovery & Development